Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tymms

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Clinical Rheumatology|April 19, 2018
Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitorsKathleen Tymms, Geoff Littlejohn, Hedley Griffiths, et al.
International Journal of Rheumatic Diseases|October 30, 2013
A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease controlGeoffrey Littlejohn, Lynden Roberts, Mark Arnold, et al.
Frontiers in Digital Health|January 26, 2023
A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experienceKathleen Tymms, Catherine O'Sullivan, Tegan Smith, et al.
Nature|February 8, 1996
Down's syndrome-like skeletal abnormalities in Ets2 transgenic miceS H Sumarsono, T J Wilson, M J Tymms, et al.
Cancer Research|August 1, 1990
Pharmacokinetics, tissue distribution, and cell localization of [35S]methionine-labeled recombinant human and murine alpha interferons in miceT G Johns, J A Kerry, B A Veitch, et al.
Oncogene|December 12, 1997
A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancerM J Tymms, A Y Ng, R S Thomas, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyClaire Owen, Gene-Siew Ngian, Kathleen Elford, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Seminars in Arthritis and Rheumatism|March 27, 2024
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence GroupAria Mohammadi Kordkheili, Charlotte Bekker, Alison M Hoens, et al.
Arthritis Research & Therapy|October 22, 2014
An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Jane Zochling, Felicity Newell, Jac C Charlesworth, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Clinical Rheumatology|April 19, 2018
Treatment patterns among patients with rheumatic disease (rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated arthritis (UnA)) treated with subcutaneous TNF inhibitorsKathleen Tymms, Geoff Littlejohn, Hedley Griffiths, et al.
International Journal of Rheumatic Diseases|October 30, 2013
A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease controlGeoffrey Littlejohn, Lynden Roberts, Mark Arnold, et al.
Frontiers in Digital Health|January 26, 2023
A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experienceKathleen Tymms, Catherine O'Sullivan, Tegan Smith, et al.
Nature|February 8, 1996
Down's syndrome-like skeletal abnormalities in Ets2 transgenic miceS H Sumarsono, T J Wilson, M J Tymms, et al.
Cancer Research|August 1, 1990
Pharmacokinetics, tissue distribution, and cell localization of [35S]methionine-labeled recombinant human and murine alpha interferons in miceT G Johns, J A Kerry, B A Veitch, et al.
Oncogene|December 12, 1997
A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancerM J Tymms, A Y Ng, R S Thomas, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort StudyClaire Owen, Gene-Siew Ngian, Kathleen Elford, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Seminars in Arthritis and Rheumatism|March 27, 2024
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence GroupAria Mohammadi Kordkheili, Charlotte Bekker, Alison M Hoens, et al.
Arthritis Research & Therapy|October 22, 2014
An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3Jane Zochling, Felicity Newell, Jac C Charlesworth, et al.
Pageof 16